This is your simplest, smartest, and most sustainable path to transforming your body and reclaiming control over your cravings, energy, and confidence whether youre on a GLP-1 medication (Ozempic, Wegovy, Mounjaro) or not
PT-141 Research# PT-141 completed the full drug development pathway: RECONNECT trials : Two Phase 3 pivotal trials in premenopausal women with HSDD demonstrated statistically significant improvements in sexual desire scores compared to placebo, with a meaningful increase in satisfying sexual events FDA approval : Approved June 21, 2019, as Vyleesi for HSDD in premenopausal women Male sexual dysfunction : Earlier trials explored PT-141 for male erectile dysfunction, though this indication was not pursued to approval Dose limitations : FDA label restricts use to no more than 8 doses per month and recommends against use in patients with uncontrolled hypertension or cardiovascular disease Post-marketing : Ongoing pharmacovigilance with established adverse event reporting The regulatory gap between MT-2 and PT-141 is the fundamental differentiator: PT-141 has undergone the rigorous efficacy and safety evaluation required for FDA approval, while MT-2 has not
However, its always a good idea to keep your medication in its original packaging and bring a copy of your prescription, just in case
**Increases resting energy expenditure** -- your body burns more calories during normal daily activities, not just exercise 2
